Treatment with the novel TAAR1 agonist ulotaront is associated with reductions in quantitative polysomnographic REM sleep without atonia in healthy human subjects: Results of a post-hoc analysis
| Autor: | Feemster, John C., Westerland, Sarah M., Gossard, Thomas R., Steele, Tyler A., Timm, Paul C., Jagielski, Jack T., Strainis, Emma, McCarter, Stuart J., Hopkins, Seth C., Koblan, Kenneth S., St. Louis, Erik K. |
|---|---|
| Zdroj: | In Sleep Medicine January 2023 101:578-586 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect